PituitaryHumansTolvaptanFemaleMaleAdult
Management of water and electrolyte disorders post-pituitary adenoma surgery: experience with Tolvaptan 7.5 mg at a tertiary care centre.
Chethan Yamichannaiah, Kaushal VinayKumar Sheth, Anurag Ranjan Lila, Vijaya Sarathi, Virendra Patil, Saba Samad Memon, Rohit Barnabas, Manjiri Karlekar, Aditya Phadte, Anima Sharma, Tushar Bandgar
Published: 202510.1007/s11102-025-01592-3
Abstract
BACKGROUND: Water and electrolyte disorders (WED) are common after pituitary surgery, increasing morbidity and hospital stay. We report our single-centre experience, with emphasis on tolvaptan use for syndrome of inappropriate antidiuresis (SIAD). ME…
Preview only. Read the full abstract at the source